Moira A. Rynn

8.0k total citations · 1 hit paper
93 papers, 5.2k citations indexed

About

Moira A. Rynn is a scholar working on Clinical Psychology, Experimental and Cognitive Psychology and Psychiatry and Mental health. According to data from OpenAlex, Moira A. Rynn has authored 93 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Clinical Psychology, 62 papers in Experimental and Cognitive Psychology and 31 papers in Psychiatry and Mental health. Recurrent topics in Moira A. Rynn's work include Child and Adolescent Psychosocial and Emotional Development (66 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (58 papers) and Attention Deficit Hyperactivity Disorder (21 papers). Moira A. Rynn is often cited by papers focused on Child and Adolescent Psychosocial and Emotional Development (66 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (58 papers) and Attention Deficit Hyperactivity Disorder (21 papers). Moira A. Rynn collaborates with scholars based in United States, Czechia and Spain. Moira A. Rynn's co-authors include Karl Rickels, Anne Marie Albano, John S. March, Scott N. Compton, John Piacentini, Golda S. Ginsburg, John T. Walkup, Boris Birmaher, Joel Sherrill and James T. McCracken and has published in prestigious journals such as New England Journal of Medicine, American Journal of Psychiatry and PEDIATRICS.

In The Last Decade

Moira A. Rynn

88 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cognitive Behavioral Therapy, Sertraline, or a Combination in Childhood Anxiety

2008 934 citations John T. Walkup, Anne Marie Albano et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Moira A. Rynn United States	39	3.8k	2.5k	1.4k	803	725	93	5.2k
Michael Van Ameringen Canada	40	3.4k 0.9×	2.2k 0.9×	967 0.7×	291 0.4×	623 0.9×	131	5.5k
Taryn L. Mayes United States	36	2.9k 0.8×	1.0k 0.4×	1.6k 1.1×	265 0.3×	628 0.9×	138	4.7k
Joel Sherrill United States	31	3.1k 0.8×	1.7k 0.7×	1.2k 0.9×	745 0.9×	675 0.9×	53	4.2k
Karen Dineen Wagner United States	42	4.5k 1.2×	1.1k 0.4×	4.2k 2.9×	330 0.4×	654 0.9×	145	7.5k
Gisele Gus Manfro Brazil	35	2.5k 0.7×	1.5k 0.6×	782 0.6×	250 0.3×	599 0.8×	177	4.2k
Matthew T. Feldner United States	45	3.7k 1.0×	2.6k 1.1×	436 0.3×	254 0.3×	718 1.0×	149	5.8k
Kirk J. Brower United States	48	1.4k 0.4×	2.5k 1.0×	524 0.4×	453 0.6×	493 0.7×	133	6.1k
Dara Sakolsky United States	33	2.6k 0.7×	1.3k 0.5×	1.4k 1.0×	557 0.7×	419 0.6×	98	3.5k
Anne Marie Albano United States	46	7.0k 1.8×	3.5k 1.4×	1.4k 1.0×	2.0k 2.5×	1.3k 1.8×	135	8.2k
Martine F. Flament Canada	36	3.1k 0.8×	661 0.3×	1.1k 0.8×	335 0.4×	355 0.5×	79	4.3k

Countries citing papers authored by Moira A. Rynn

Since Specialization

Citations

This map shows the geographic impact of Moira A. Rynn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moira A. Rynn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moira A. Rynn more than expected).

Fields of papers citing papers by Moira A. Rynn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moira A. Rynn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moira A. Rynn. The network helps show where Moira A. Rynn may publish in the future.

Co-authorship network of co-authors of Moira A. Rynn

This figure shows the co-authorship network connecting the top 25 collaborators of Moira A. Rynn. A scholar is included among the top collaborators of Moira A. Rynn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moira A. Rynn. Moira A. Rynn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goldberg, Pablo H., et al.. (2025). Ketamine Treatment for Pediatric Refractory Obsessive: Five Open Label Cases. Journal of Child and Adolescent Psychopharmacology. 35(3). 167–170.

Bushnell, Greta, Moira A. Rynn, Tobias Gerhard, et al.. (2023). Drug overdose risk with benzodiazepine treatment in young adults: Comparative analysis in privately and publicly insured individuals. Addiction. 119(2). 356–368. 2 indexed citations

Rynn, Moira A., et al.. (2023). Impact of the Youth Behavioral Health Crisis in North Carolina. North Carolina Medical Journal. 84(5). 293–298.

Strawn, Jeffrey R., Jeffrey A. Mills, Dara Sakolsky, et al.. (2017). Placebo Response in Pediatric Anxiety Disorders: Results from the Child/Adolescent Anxiety Multimodal Study. Journal of Child and Adolescent Psychopharmacology. 27(6). 501–508. 25 indexed citations

Strawn, Jeffrey R., Scott N. Compton, Brigitte Robertson, et al.. (2017). Extended Release Guanfacine in Pediatric Anxiety Disorders: A Pilot, Randomized, Placebo-Controlled Trial. Journal of Child and Adolescent Psychopharmacology. 27(1). 29–37. 38 indexed citations

Rickels, Karl, Bijan Etemad, Moira A. Rynn, et al.. (2013). Remission of Generalized Anxiety Disorder after 6 Months of Open-Label Treatment with Venlafaxine XR. Psychotherapy and Psychosomatics. 82(6). 363–371. 6 indexed citations

Almirall, Daniel, Scott N. Compton, Moira A. Rynn, John T. Walkup, & Susan A. Murphy. (2012). SMARTer Discontinuation Trial Designs for Developing an Adaptive Treatment Strategy. Journal of Child and Adolescent Psychopharmacology. 22(5). 364–374. 19 indexed citations

Caporino, Nicole E., Douglas M. Brodman, Philip C. Kendall, et al.. (2012). Defining Treatment Response and Remission in Child Anxiety: Signal Detection Analysis Using the Pediatric Anxiety Rating Scale. Journal of the American Academy of Child & Adolescent Psychiatry. 52(1). 57–67. 61 indexed citations

Strawn, Jeffrey R., Dara Sakolsky, & Moira A. Rynn. (2012). Psychopharmacologic Treatment of Children and Adolescents with Anxiety Disorders. Child and Adolescent Psychiatric Clinics of North America. 21(3). 527–539. 33 indexed citations

10.

Shen, Sa, et al.. (2011). Screening Parents During Child Evaluations: Exploring Parent and Child Psychopathology in the Same Clinic. Journal of the American Academy of Child & Adolescent Psychiatry. 50(5). 441–450. 44 indexed citations

11.

Barber, Jacques P., Marna S. Barrett, Robert Gallop, Moira A. Rynn, & Karl Rickels. (2011). Short-Term Dynamic Psychotherapy Versus Pharmacotherapy for Major Depressive Disorder. The Journal of Clinical Psychiatry. 73(1). 66–73. 91 indexed citations

12.

Compton, Scott N., John T. Walkup, Anne Marie Albano, et al.. (2010). Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods. Child and Adolescent Psychiatry and Mental Health. 4(1). 1–1. 262 indexed citations

13.

Iacoviello, Brian M., Kevin S. McCarthy, Marna S. Barrett, et al.. (2007). Treatment preferences affect the therapeutic alliance: Implications for randomized controlled trials.. Journal of Consulting and Clinical Psychology. 75(1). 194–198. 88 indexed citations

14.

Rynn, Moira A., James Russell, J. Erickson, et al.. (2007). Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial. Depression and Anxiety. 25(3). 182–189. 112 indexed citations

15.

March, John S., et al.. (2007). A Randomized Controlled Trial of Venlafaxine ER Versus Placebo in Pediatric Social Anxiety Disorder. Biological Psychiatry. 62(10). 1149–1154. 86 indexed citations

16.

Rynn, Moira A., Karen Dineen Wagner, Craig L. Donnelly, et al.. (2006). Long-Term Sertraline Treatment of Children and Adolescents with Major Depressive Disorder. Journal of Child and Adolescent Psychopharmacology. 16(1-2). 103–116. 18 indexed citations

17.

Rynn, Moira A., Jacques P. Barber, Sarosh Khalid‐Khan, et al.. (2005). The psychometric properties of the MASC in a pediatric psychiatric sample. Journal of Anxiety Disorders. 20(2). 139–157. 105 indexed citations

18.

Rynn, Moira A. & Olga Brawman‐Mintzer. (2004). Generalized Anxiety Disorder: Acute and Chronic Treatment. CNS Spectrums. 9(10). 716–723. 52 indexed citations

19.

Rickels, Karl, Nicholas DeMartinis, Felipe García‐España, et al.. (2000). Imipramine and Buspirone in Treatment of Patients With Generalized Anxiety Disorder Who Are Discontinuing Long-Term Benzodiazepine Therapy. American Journal of Psychiatry. 157(12). 1973–1979. 58 indexed citations

20.

Rickels, Karl, Nicholas DeMartinis, Moira A. Rynn, & Laura A. Mandos. (1999). Pharmacologic Strategies for Discontinuing Benzodiazepine Treatment. Journal of Clinical Psychopharmacology. 19(6 Suppl 2). 12S–16S. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact